|
Specially commissioned lectures by leading world experts.
The Biomedical & Life Sciences Collection
New Releases for July
|
|
|
|
This month’s new release to The Biomedical & Life Sciences Collection features talks on graphics in biostatistics, cutaneous leishmaniasis, ligand-based drug design and more.
The addition to the series Periodic Reports: Advances in Clinical Interventions and Research Platforms is the two part talk on ‘Peptide-drug conjugates as therapeutic modality in drug development’ by Dr. Syed Faheem Askari Rizvi, Xiamen University, China. In his talk, Dr. Rizvi provides an overview of peptide drugs and peptide-drug conjugates (PDCs), discussing receptor-targeting peptides currently undergoing clinical trials as well as some already approved by the FDA. He also explores conjugation of peptides with fluorescence dyes and radionuclides, along with PDCs designed using pH-dependent linkers – demonstrating how these developments are transforming cancer treatment.
A complete list of the released talks is provided below.
Kind regards,
The Editorial Team
|
|
|
|
|
Peptide-drug conjugates as therapeutic modality in drug development
Dr. Syed Faheem Askari Rizvi
Xiamen University, China
|
|
|
|
|
|
Special senses: vision – eye movement
Dr. Helena Lee
University of Southampton, UK
|
|
|
|
|
|
Graphics in biostatistics: prepared using the R language
Dr. Thomas W. MacFarland
Nova Southeastern University, USA
|
|
|
|
|
|
Innovations in antibiotic discovery: combating resistant infections
Prof. Mark Blaskovich
The University of Queensland, Australia
|
|
|
|
|
|
Cutaneous leishmaniasis
Dr. Michael Chance
Liverpool School of Tropical Medicine, UK
|
|
|
|
|
|
Cytomegalovirus in pediatric solid organ transplant recipients
Dr. Kevin J. Downes
University of Pennsylvania, USA
|
|
|
|
|
|
Ligand-based drug design in the AlphaFold age
Dr. David Clark
Charles River Laboratories, UK
|
|
|
|
|
New Series – Pharmaceutical Marketing
|
|
|
Digital marketing in pharmaceuticals
Ms. Liz Presson
Founder & CEO, Pursuit, USA
|
|
|
|
|
|
Positioning and branding in pharmaceuticals
Mr. Richard D. Czerniawski
Brand Development Network International, USA
|
|
|
|
|
|
The US payer landscape
Mr. Keith Kelly
Syneos Health, USA
|
|
|
|
|
|
Emerging trends in pharmaceutical marketing
Mr. Sanjay Tripathi
iXM Pro, USA
|
|
|
|
|
|
Effective promotion and advertising in pharmaceutical marketing
Mr. Francesco Lucarelli
CCO, Boundless Life Sciences Group, USA
|
|
|
|
|
New in Nuclear Receptors as Common Therapeutic Targets
|
|
|
Mechanisms of nuclear receptor activation by ligands
Prof. Dr. Daniel Merk
Ludwig-Maximilians-University (LMU), Germany
|
|
|
|
|
|
Thyroid hormone receptors (NR1A): biological role & drugs
Prof. Dr. Daniel Merk
Ludwig-Maximilians-University (LMU), Germany
|
|
|
|
|
New Research and Clinical Interviews
|
|
|
Advancing ALS genetics through accessible testing
Dr. Teresa Fecteau
Biogen, USA
|
|
|
|
|
|
Pioneering proteomics: insights on advancements in the science of proteins
Prof. Ruedi Aebersold
ETH Zurich, Switzerland
|
|
|
|
|
|
From lab to clinic: bridging cancer genetics and public health
Prof. Clare Turnbull
Institute of Cancer Research, UK
|
|
|
|
|
Featured talks from previous releases
|
|
|
|
|
|
For more specially commissioned lectures:
|
|
For assistance, contact HSTalks subscriber support:
Subscriber Support, Henry Stewart Talks Ltd
Tel: +44 (0) 20 7092 3480, Email: access@hstalks.com
Address: 40/41 Museum Street, London WC1A 1LT, United Kingdom
|
|
Follow us
|
 |
 |
|
